The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions

被引：51
作者：
Khezri, Mohammad Rafi [1 ]
Jafari, Reza [2 ]
Yousefi, Keyvan [3 ]
Zolbanin, Naime Majidi [4 ,5 ,6 ]
机构：
[1] Urmia Univ Med Sci, Student Res Comm, Orumiyeh, Iran
[2] Urmia Univ Med Sci, Cellular & Mol Med Inst, Cellular & Mol Res Ctr, Orumiyeh, Iran
[3] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33146 USA
[4] Urmia Univ Med Sci, Expt & Appl Pharmaceut Sci Res Ctr, Orumiyeh, Iran
[5] Urmia Univ Med Sci, Sch Pharm, Dept Pharmacol & Toxicol, Orumiyeh, Iran
[6] Urmia Univ Med Sci, Sch Fac Pharm, Dept Pharmacol & Toxicol, Sero Rd, Orumiyeh, Iran
来源：
EXPERIMENTAL AND MOLECULAR PATHOLOGY | 2022年 / 127卷
关键词：
Angiogenesis; Apoptosis; Cancer; PI3K; AKT; CELL LUNG-CANCER; INHIBITS TUMOR ANGIOGENESIS; GROWTH-FACTOR RECEPTOR; I KAPPA B; BREAST-CANCER; GASTRIC-CANCER; OVARIAN-CANCER; PANCREATIC-CANCER; UP-REGULATION; COLON-CANCER;
D O I：
10.1016/j.yexmp.2022.104787
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
The human body consists of countless cells with the possibility of excessive and uncontrolled proliferation under certain dysregulated circumstances that could cause abnormal states such as cancer. Phosphatidylinositol 3 kinase (PI3K) and its downstream target, Protein kinase B or AKT, play a critical role in cell survival, proliferation, differentiation, migration, and metabolism. Research studies have examined the aberrant expression of signaling molecules that regulate PI3K/AKT pathway with the purpose of target discovery. The present review aims to recapitulate the relationship between the PI3K/AKT signaling pathway and factors contributing to initiation and development of various cancers. In addition, therapeutic interventions regulating this signaling pathway have been summarized.
引用
收藏
页数：12
相关论文
共 200 条
  • [41] Fortier Anne-Marie, 2011, Biomol Concepts, V2, P1, DOI 10.1515/bmc.2011.003
  • [42] Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells
    Fu, Xin
    Tian, Jing
    Zhang, Lei
    Chen, Ying
    Hao, Quan
    [J]. FEBS LETTERS, 2012, 586 (09) : 1279 - 1286
  • [43] Notch1 regulates tongue cancer cells proliferation, apoptosis and invasion
    Gan, Rui-Huan
    Wei, Hua
    Xie, Jing
    Zheng, Dan-Ping
    Luo, Er-Ling
    Huang, Xiao-Yu
    Xie, Jian
    Zhao, Yong
    Ding, Lin-Can
    Su, Bo-Hua
    Lin, Li-Song
    Zheng, Da-Li
    Lu, You-Guang
    [J]. CELL CYCLE, 2018, 17 (02) : 216 - 224
  • [44] Interleukin-6: A Critical Cytokine in Cancer Multidrug Resistance
    Ghandadi, Morteza
    Sahebkar, Amirhossein
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (05) : 518 - 526
  • [45] PML Regulates Apoptosis at Endoplasmic Reticulum by Modulating Calcium Release
    Giorgi, Carlotta
    Ito, Keisuke
    Lin, Hui-Kuan
    Santangelo, Clara
    Wieckowski, Mariusz R.
    Lebiedzinska, Magdalena
    Bononi, Angela
    Bonora, Massimo
    Duszynski, Jerzy
    Bernardi, Rosa
    Rizzuto, Rosario
    Tacchetti, Carlo
    Pinton, Paolo
    Pandolfi, Pier Paolo
    [J]. SCIENCE, 2010, 330 (6008) : 1247 - 1251
  • [46] miRNA-221 promotes cutaneous squamous cell carcinoma progression by targeting PTEN
    Gong, Zhen-Hua
    Zhou, Feng
    Shi, Chao
    Xiang, Tie
    Zhou, Chang-Kai
    Wang, Qian-Qian
    Jiang, Ya-Su
    Gao, Sheng-Feng
    [J]. CELLULAR & MOLECULAR BIOLOGY LETTERS, 2019, 24 (1)
  • [47] Multidrug resistance in cancer: Role of ATP-dependent transporters
    Gottesman, MM
    Fojo, T
    Bates, SE
    [J]. NATURE REVIEWS CANCER, 2002, 2 (01) : 48 - 58
  • [48] P-glycoprotein and multidrug resistance
    Gottesman, MM
    Pastan, I
    Ambudkar, SV
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 1996, 6 (05) : 610 - 617
  • [49] Gulati N, 2006, ANTICANCER RES, V26, P1177
  • [50] Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines
    Guo, Dongmei
    Ye, Jingjing
    Dai, Jianjian
    Li, Lizhen
    Chen, Feng
    Ma, Daoxin
    Ji, Chunyan
    [J]. LEUKEMIA RESEARCH, 2009, 33 (05) : 678 - 685
12345678910